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Abstract Alzheimer's disease is in part characterised by the 
deposit of ~-amyloid peptide in the form of fibrils in the brain. 
In this study, the scanning tunnelling microscope (STM) has been 
used to provide high resolution images of synthetic fibril structure 
and formation as a function of time. Short fibrils are observed 
following brief peptide incubation times. At longer incubation 
periods ribbon like filaments were observed. These results suggest 
that ~-amyloid self-assembly is an ordered process, with a corre- 
lation between time of incubation and length of/3-amyloid fila- 
ment growth. 
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1. Introduction 
Alzheimer's disease is the major cause of dementia nd the 
fourth leading cause of death in the developed world after heart 
disease, cancer and stroke. It has been estimated that it afflicts 
10% of the population aged over 65 years [1,2]. The disease 
begins with the loss of short-term emory followed by progres- 
sive dementia [3]. A major pathological feature of Alzheimer's 
disease in the brain tissue of patients is the presence of a high 
density of amyloid plaques urrounded by neurons containing 
neurofibrillary tangles. Similar neuropathology is also evident 
in people with Down's Syndrome by their late thirties and 
appears also, in a reduced form, to be characteristic of the 
normal ageing process [4]. The amyloid of the plaques is com- 
posed of aggregations of fl-amyloid peptide of 39-43 amino 
acid residues in length. The predominant peptide length de- 
pends on factors such as the type of plaque, its anatomical 
location, genotype and disease type. The fl-amyloid peptide 
(1-40) sequence is shown in Fig. 1. fl-Amyloid is derived from 
a transmembrane protein, amyloid precursor protein (APP), 
whose gene is located on chromosome 21[5,6]. It is thought that 
abnormal post-translational modification of APP yields fl-amy- 
loid [7,8]. The neurotoxicity of fl-amyloid is believed to be 
related to its self-assembly into long dense fibrils [9-13], which 
may act as cation-specific ion channels [14]. 
In an effort to understand the mechanism of molecular self- 
assembly we have studied the process of synthetic fl-amyloid 
fibrilization using the scanning tunnelling microscope (STM). 
*Corresponding author. Fax: (44) (115) 9515110. 
This instrument measures surface conductivity and is able to 
obtain topographical data in the nanometre to sub-nanometre 
range by monitoring the flow of current between a sharp probe 
and a surface [15]. In the last decade, the STM has found 
application i  the fields of chemistry, physics, engineering and 
biology [1618]. However, the poor electron conductivity of 
most biological samples has hampered the progress of direct 
imaging of macromolecules. To overcome this problem we have 
employed metal coating, which has the added benefit of physi- 
cally immobilizing the sample [19]. Other potential protocols 
include chemical immobilization [20] or the use of high affinity 
binding systems [21]. 
The fl-amyloid peptide is able to assemble in an aqueous 
environment [22-25]. In the present study we examine the effect 
of peptide incubation time on synthetic fl-amyloid fibril struc- 
ture and size. The samples, prepared for STM, allow a direct 
correlation of incubation time with structural elongation. 
2. Materials and methods 
2.1. Preparation of ~-amyloid fibres 
Synthetic fl-amyloid (140) (Fig. 1) was obtained from Bachem (Tor- 
rance, California, USA). Samples were prepared to an initial stock 
solution concentration f 2 mg/ml using 0.1% acetic acid as the solvent. 
They were then stored at -20 °C to avoid fibrilization of amyloid. 
Self-assembly was initiated by dilution of stock solution to a concentra- 
tion of 30 gtg/ml (pH 4.5) by addition of the appropriate quantity of 
buffer. Aliquots of the sample were then incubated at 37°C for various 
time intervals. 
2.2. Sample preparation 
Immediately following dilution of the peptide and ageing, 4pl of the 
respective solution was deposited onto freshly cleaved mica (Agar Sci- 
entific Ltd, Stansted, Essex, UK). The macromolecules were allowed 
to adsorb onto the substrate for a few minutes following which excess 
solvent was removed using filter paper. The samples were then dried 
rapidly under vacuum (10 -6 T) and coated with a thin layer of platinum- 
carbon (nominally 2 nm thick as measured by a film thickness monitor) 
by electron beam evaporation i a Fisons E6430 coater [26]. The grain 
size obtained for coatings prepared in this way was approximately 
4-5 nm as measured from STM images. 
2.3. Microscope analysis 
The samples were scanned in ambient conditions with mechanically 
prepared platinum/iridium (80:20) tips using a VG STM 2000 system 
(VG Microtech, Uckfield, UK). All the images hown were obtained 
in the constant current mode. Typical experimental conditions com- 
prised a tunnelling current between 60 to 400 pA and a tip bias voltage 
range of +0.50 to +0.97 V. The images presented are grey scale repre- 
sentations, which show the lowest points as dark pixels and the highest 
points as light pixels. In order to establish the performance of the 
0014-5793195/$9.50 © 1995 Federation of European Biochemical Societies. All rights reserved. 
SSDI 0014-5793(95)00858-6 
26 A.P Shivji et al./FEBS Letters 371 (1995) 25-28 
instrument routine images of graphite were obtained at atomic resolu- 
tion throughout the study. 
2.4. Tip deconvolution 
It is well known that scanning probe image data is often distorted by 
the geometric onstraints imposed by the probe. Image data were ana- 
lyzed using novel surface reconstruction software [27]. Here, the influ- 
ence on the image of the shape of the bluntest tip that could have 
formed the image data is found and removed from the image surface. 
Features remaining in the image must, therefore, be representative of 
the smallest possible size of that surface feature. Such analysis permits 
the binding of width values; the upper bound is the width measured 
from the raw image data, the lower is that measured from the recon- 
structed surface. Data analysis indicates that fibril lengths are not 
significantly affected by tip geometric distortion. The software does not 
take into account the increase in dimensions due to the application of 
a metallic overcoat, however in our experience this does not tend to 
cause great deviation [20]. 
3. Results and discussion 
STM analysis of the surface topography of the amyloid sam- 
ple following minimal incubation revealed the self-assembled 
peptide, as shown in Fig. 2. The 188 x 188 nm scan is typical 
of similar data taken from a number of areas. The image shows 
a discrete surface unit which possesses a fibril-like structure. In 
addition, the fibril exhibits a corrugated sub-structure. Using 
similar high resolution scans, the dimensions of 40 filaments 
were measured. The mean length of the fibrils was 79.1 nm 
(standard eviation (S.D.) = 21.6). We believe these features to 
result from self-assembling of fl-amyloid peptide. These amy- 
loid assemblies may nucleate (or seed) the formation of larger 
insoluble aggregates of amyloid from pools of soluble peptide. 
While the exact nature of these structures i unknown, the net 
result of this so-called seeding phenomena is believed to be a 
significant acceleration i the rate of aggregation offl-amyloid 
compared with unseeded material [1,28[. 
It was evident from the STM data that increased self-assem- 
bly had occurred following incubation of the peptide for 4 h at 
37°C. The 393 × 393 nm STM topograph (Fig. 3) is typical of 
data taken from a number of different areas within the pre- 
pared fl-amyloid (1-40) peptide sample after 4 h. The image 
shows numerous discrete ribbon-like filaments on the surface 
which we again interpret o be self-assembled fl-amyloid pep- 
tide [29,30]. Using higher resolution images, the dimensions of 
over 150 filaments were measured and again a heterogeneous 
size digstribution was obtained, with a mean length of 186.0 nm 
(S.D. = 59.6). A low percentage of very short fibrils of length 
around 20 nm were also clearly detected and we postulate that 
these are fl-amyloid aggregates at an early stage of fibrilization. 
There is a continued increased growth in plaque length at 
24 h, as illustrated by the low resolution scan in Fig. 5 (1.9 x 1.9 
pro). On analyzing the lengths of a large number of fibrils 
(n = 95), the mean length of the data was found to be 395.6 nm 
(S.D. = 144.9). 
The STM image in Fig. 6, is typical of the sets of data 
recorded from a number of areas within the replicas analyzed 
following fl-amyloid incubation for 216 h. The 1.8 x 1.8/zm 
H2N-Asp-Ala-Glu-Phe-Arg-His-Asp-Ser-Gly-Tyr-Glu-VaI-His-His-GIn-Lys- 
Leu-VaI-Phe-Phe-Ala-Glu-Asp-VaI-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu- 
Met-VaI-Gly-Gly-Val-VaI-COOH 
Fig. 1. The fl-amyloid (1-40) peptide sequence (the three letter code for 
amino acids has been utilized). 
Fig. 2. STM image of coated samples prepared at t -- 0 h. High resolu- 
tion scan showing the distinct fibril morphology of fl-amyloid. Scan 
size: 188 x 188 x 10.7 nm. 
scan, shows a fl-amyloid aggregate in the centre of the image. 
This single strand is flanked by a number of smaller surface 
units which we believe to be either smaller assemblies which 
may in time form larger self-assembled structures or debris as 
a result of long fl-amyloid fibrils breaking up during the sample 
drying phase of the preparation. The high resolution topograph 
in Fig. 7 shows a number of long peptide aggregates which 
appear to exhibit a disjointed structure. This morphological 
Fig. 3. STM image showing a number of discrete fl-amyloid (1-40) 
surface units with a characteristic ribbon-like filament structure. Scan 
size: 393 x 393 × 11.5 nm. Coated samples prepared at t = 4 h. 
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Fig. 4. High resolution STM image of a single fl-amyloid (140) fibril 
clearly exhibiting a striated morphology. Scan size 85 × 85 x 8.8 nm. Fig. 6. Coated samples at t = 216 h. STM topographs of self-assembled ribbon like structures of fl-amyloid (140) peptide. Scan size:1797 × 
1797 × 40.8 nm. 
feature is consistently repeated within a particular fibril, but 
differs between filaments. This variation in topography may be 
indicative of the angle of deposition of the fibril or represent 
the disruption involved caused by the drying processes. On 
analyzing the data, it was decided to eliminate any fibrils of 
length less than 750 nm, as aggregates of this length have been 
observed at 24 h and may be debris. The mean length of 39 
fibres was found to be 1149.6 nm (S.D. = 301.4). 
An analysis of the surface morphology also entailed an as- 
sessment of the width of the fibrils. In contrast o fibril length, 
the measurement of widths were more consistent for most of  
the self-assembled peptides and the average was found to be 
25.3 nm (S.D. = 4.2). Using higher resolution images, similar 
to Fig. 4, it became evident he fibrils possessed a pronounced 
corrugated morphology (indicated with arrows). There appears 
to be a broad region followed by a narrower area, and on 
analysis it was found that this unit is repeated every 12 nm. This 
variation in width has been reported previously using transmis- 
Fig. 5. STM image showing an apparent enlarging of the biomolecules 
length due to a self-assembling process, after incubation for 24 h. Scan 
size 1986 x 1986 x 19.6 nm. 
Fig. 7. Higher resolution scan showing disjointed structure of large 
fibrils. Scan size 530 x 530 × 25.1 nm. 
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Table 1 
Analysis of mean dimensions of coated synthetic fl-amyloid (1-40) peptide at various incubation times by STM 
Mean length /nm at 0 h Mean length /nm at 4 h Mean length /nm at 24 h Mean length /nm at 216 h Mean width/nm* 
79.1 + 21.6 186.0 + 59.6 395.6 + 144.9 1149.6 + 301.4 25.3 + 4.2 
*STM data shown here correlate well with TEM data (unpublished) 
sion electron microscopy (TEM) [31]. An analysis of the tip 
induced effects indicated that the images obtained had not been 
distorted significantly by the probe and the features viewed 
were a true indication of the sample morphology. In addition, 
the STM data correlates well to data sets obtained with TEM, 
for samples prepared by coating with platinum-carbon [unpub- 
lished]. 
The experiments undertaken have produced high resolution 
data of fl-amyloid fibrils. Initially small self-assembled rod 
shaped structures were observed. Following molecular self-as- 
sembly in solution a consistent ribbon like filament morphol- 
ogy was observed by STM. The surface topography was one 
of alternating areas of broad and slim regions within the amy- 
loid structure. A summary of the data (Table 1) indicates a 
correlation between longitudinal fibre elongation, as deter- 
mined by STM, and the time of incubation. Our results uggest 
that fl-amyloid elongation is an ordered process in solution, 
with a quantifiable amount of fibril growth achievable in a set 
time. 
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